Bluetooth sub-segment is Predicted to be the Dominate the Global Connected Drug Delivery Devices Market During 2021-2030

According to a new report published by Allied Market Research, titled, "Connected Drug Delivery Devices Market," The connected drug delivery devices market size was $290.30 million in 2021, and is estimated to reach $2.1 billion by 2030, growing at a CAGR of 24.3% from 2022 to 2030.

Connected drug delivery devices, encompassing wireless connectivity and smart electronic features, facilitate patient-administered therapy. These devices, including auto-injectors, smart inhalers, and closed-loop solutions, have shown promise in enhancing patient adherence and minimizing dosing errors, particularly in home settings. They cater to various medical conditions such as multiple sclerosis, diabetes, liver and renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/26467

These devices enable physicians to monitor patient compliance with prescribed therapies and adjust treatments as needed. Efforts to raise awareness about the complexities of medication dosages are expected to drive the adoption of connected drug delivery devices. Patients grappling with chronic diseases like asthma and diabetes encounter challenges in medication management, prescription adherence, healthcare provider visits, and dietary balance. Connected drug delivery devices offer self-management solutions by promoting adherence to prescribed treatments.

However, a key hurdle to widespread adoption lies in the cost-effective integration of user-friendly electronic communication systems. Despite being mechanically simple and mass-produced at low cost, these devices require seamless integration into existing wireless networks, which often involves pairing procedures, passwords, apps, and subscriptions. These complexities can detract from the device's reliability and usability for patients.

The significant focus on technological advancements is driving notable growth in the market. For example, the swift adoption of nanotechnology by manufacturers has led to more precise drug delivery and enhanced drug penetration at target sites, reducing errors. Key drug manufacturers are utilizing liposomal technologies such as DepoFoam TM Technology and Non-PEGylated Technology (NPL) to achieve extended-release drug delivery, consequently lowering dosages and minimizing side effects, thereby improving patient adherence.

Moreover, the rapid adoption of advanced and intricate technologies to develop unique drugs, ensuring competitiveness, is anticipated to bolster revenue growth in the connected drug delivery devices market over the forecast period.

The global market for connected drug delivery devices is segmented by type, technology, end-user, and region. Types include injectable devices, inhalation devices, and others. Technologies encompass NFC, Bluetooth, and others. End-users are categorized into homecare settings and hospitals. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

𝑯𝒂𝒗𝒆 𝑨𝒏𝒚 𝑸𝒖𝒆𝒓𝒚? 𝑨𝒔𝒌 𝑶𝒖𝒓 𝑬𝒙𝒑𝒆𝒓𝒕 @ https://www.alliedmarketresearch.com/purchase-enquiry/26467

𝑲𝒆𝒚 𝑭𝒊𝒏𝒅𝒊𝒏𝒈𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑺𝒕𝒖𝒅𝒚
Based on type, the injectable devices sub-segment emerged as a dominating leader in 2021 and the inhalation devices are anticipated to be the fastest growing sub-segment during the forecast period
Based on technology, the NFC sub-segment emerged as the fastest growing sub-segment and the Bluetooth sub-segment is predicted to be the dominating in the upcoming years
Based on end-user, the homecare settings sub-segment emerged as the fastest growing and the hospitals sub-segment is predicated as dominating in the market during the forecast period
Based on region, the North America market registered the highest market share in 2021 and Asia-Pacific region is anticipated to be the fastest growing in the market during the forecast period.

𝒌𝒆𝒚 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒍𝒂𝒚𝒆𝒓𝒔
Syncro Technology Corp.
West Pharmaceutical Services, Inc.
Cohero Health, Inc.
Adherium
F. Hoffmann-La Roche Ltd
Proteus Digital Health
AptarGroup Inc.
PROPELLER HEALTH
Ypsomed AG
BD

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

𝑲𝒏𝒐𝒘 𝑴𝒐𝒓𝒆- https://www.alliedmarketresearch.com/connected-drug-delivery-devices-market-A26017

𝑶𝒕𝒉𝒆𝒓 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑳𝒊𝒇𝒆 𝑺𝒄𝒊𝒆𝒏𝒄𝒆 𝑫𝒐𝒎𝒂𝒊𝒏-
𝑽𝒊𝒅𝒆𝒐 𝑳𝒂𝒓𝒚𝒏𝒈𝒐𝒔𝒄𝒐𝒑𝒆 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/video-laryngoscope-market-A17524

𝑺𝒊𝒄𝒌𝒍𝒆 𝑪𝒆𝒍𝒍 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/sickle-cell-disease-treatment-market-A31450

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.